Nanotechnology promises a revolution in pharmacology to improve or create ex novo therapies. Cerium oxide nanoparticles (nanoceria), well-known as catalysts, possess an astonishing pharmacological potential due to their antioxidant properties, deriving from a fraction of Ce³⁺ ions present in CeO₂. These defects, compensated by oxygen vacancies, are enriched at the surface and therefore in nanosized particles. Reactions involving redox cycles between the Ce³⁺ and Ce⁴⁺ oxidation states allow nanoceria to react catalytically with superoxide and hydrogen peroxide, mimicking the behavior of two key antioxidant enzymes, superoxide dismutase and catalase, potentially abating all noxious intracellular reactive oxygen species (ROS) via a self-regenerating mechanism. Hence nanoceria, apparently well tolerated by the organism, might fight chronic inflammation and the pathologies associated with oxidative stress, which include cancer and neurodegeneration. Here we review the biological effects of nanoceria as they emerge from in vitro and in vivo studies, considering biocompatibility and the peculiar antioxidant mechanisms.

The increasing world population and the need to improve quality of life for a large percentage of human beings are the driving forces for the search for sustainable energy production systems, alternative to fossil fuel combustion. Among the various types of alternative energy production technologies, solid oxide fuel cells (SOFCs) operating at intermediate temperatures (400–700 °C) show the advantage of possible use both for stationary and mobile energy production. To reach the goal of reducing the SOFC operating temperature, proton-conducting oxides are gaining wide interest as electrolyte materials. This critical review provides a broad overview of the most recent progresses obtained tailoring the properties of proton-conducting oxides for fuel cell applications, analyzing and comparing the different strategies proposed to match high-proton conductivity with good chemical stability (170 references).